Evidence map›Paper›PMID 39907115›Full record

ArticleCancer biology & medicine2025

Integrating artificial intelligence into radiological cancer imaging: from diagnosis and treatment response to prognosis.

Sunyi Zheng, Xiaonan Cui, Zhaoxiang Ye

Abstract readEditorial
In one paragraph

Article in Cancer biology & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. AI in Prostate MRI: A Task-Based Review.Journal of the Korean Society of Radiology · 2025
    Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sunyi Zheng *Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Radiology, Tianjin 300060, China.
Xiaonan Cui *Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Radiology, Tianjin 300060, China.
Zhaoxiang YeTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Radiology, Tianjin 300060, China.ORCID 0000-0003-3157-8393

Funding

Chinese National Key Research and Development Project 2021YFC2500400Chinese National Key Research and Development Project 2021YFC2500402Ministry of Science and Technology of China 2024ZD0520002National Health Commission Capacity Building and Continuing Education Center YXFSC2022JJSJ011National Natural Science Foundation of China 82171932National Natural Science Foundation of China 82302180Scientific Developing Foundation of Tianjin Education Commission 2024KJ182Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-010A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39907115
PMCPMC11795265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.